Aramark
ARMK
55.42
-0.03
-0.05%
Aramark
US · ARMK
#1172 by market cap
Listed 1970
55.42
-0.03
-0.05%
Live - 5344 symbols - heartbeat 112s ago
· 2026-10-08 01:16
After-hours
55.42
0.00%
Overnight
55.81
+0.70%
- Market cap
- 14.61B
- P/E (TTM)i
- 38.76
- P/Bi
- 4.30
- EPSi
- 1.22
- Div yieldi
- 0.84%
- 52W posi
- 74%
Reader sentiment
Are you bullish or bearish on ARMK?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.50, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +6.35% YoY
Margins
- Gross margin
- 8.36%
- Operating margin
- 4.28%
- Net margin
- 1.76%
Key ratios & quality
- Enterprise valuei
- 19.44B
- PEG ratioi
- 2.06
- Altman Z-Scorei
- 2.50
PEG uses trailing P/E against the 3-year net income growth rate (18.84%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 15.79B | 16.23B | 12.83B | 12.10B | 13.69B | 16.08B | 17.40B | 18.51B |
| Gross profit | 1.79B | 1.69B | 835.89M | 1.09B | 1.07B | 1.31B | 1.43B | 1.55B |
| Selling & admin expenses | 377.13M | 367.26M | 307.02M | 346.75M | 258.36M | 273.66M | 283.63M | 278.44M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 818.41M | 734.85M | -66.32M | 191.44M | 415.39M | 625.03M | 706.51M | 791.85M |
| Pretax profit | 471.88M | 556.17M | -647.72M | -132.85M | 47.21M | 563.52M | 364.87M | 430.46M |
| Tax | -96.56M | 107.71M | -186.28M | -40.63M | 8.43M | 116.43M | 102.97M | 103.59M |
| Net profit | 568.44M | 448.47M | -461.44M | -92.22M | 194.18M | 673.53M | 261.89M | 326.87M |
| Basic EPS | 2 | 2 | -2 | 0 | 1 | 3 | 1 | 1 |
| Diluted EPS | 2.24 | 1.78 | -1.83 | -0.36 | 0.75 | 2.57 | 0.99 | 1.22 |
| Line item | 2025-03 | 2025-06 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 4.28B | 4.63B | 5.05B | 4.83B | 4.91B | 5.06B |
| Gross profit | 359.60M | 370.11M | 416.02M | 416.18M | 426.44M | 430.34M |
| Selling & admin expenses | 68.41M | 65.70M | 73.94M | 72.67M | 74.49M | 78.63M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 174.13M | 182.59M | 217.82M | 217.55M | 219.80M | 215.59M |
| Pretax profit | 84.47M | 96.19M | 108.34M | 135.63M | 137.51M | 135.73M |
| Tax | 22.50M | 24.23M | 21.10M | 39.13M | 35.37M | 37.90M |
| Net profit | 61.97M | 71.95M | 87.24M | 96.50M | 102.14M | 97.83M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.23 | 0.27 | 0.33 | 0.36 | 0.38 | 0.36 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 2.90B | 2.66B | 4.68B | 2.90B | 3.29B | 5.22B | 3.41B | 3.52B |
| Cash & ST investments | 215.03M | 246.64M | 2.51B | 532.59M | 329.45M | 2.04B | 714.83M | 639.10M |
| Inventory | 724.80M | 411.32M | 436.47M | 412.68M | 552.39M | 403.71M | 387.60M | 418.77M |
| Total assets | 13.72B | 13.74B | 15.71B | 14.38B | 15.08B | 16.87B | 12.67B | 13.30B |
| Total current liabilities | 2.49B | 2.71B | 2.35B | 2.86B | 3.29B | 5.03B | 4.21B | 3.55B |
| Short-term debt | 30.91M | 69.93M | 171.73M | 126.13M | 133.91M | 1.59B | 1.02B | 92.29M |
| Long-term debt | 7.21B | 6.61B | 9.18B | 7.39B | 7.35B | 5.10B | 4.31B | 5.37B |
| Total liabilities | 10,680,451,000.00 | 10,406,359,000.00 | 12,966,708,000.00 | 11,644,242,000.00 | 12,043,956,000.00 | 13,150,299,000.00 | 9,627,903,000.00 | 10,142,440,000.00 |
| Total equity | 3.04B | 3.33B | 2.75B | 2.73B | 3.04B | 3.72B | 3.05B | 3.16B |
| Retained earnings | 710.52M | 1.11B | 532.38M | 327.56M | 406.78M | 964.16M | 239.71M | 453.28M |
| Line item | 2025-03 | 2025-06 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 3.84B | 3.53B | 3.52B | 3.63B | 3.75B | 3.86B |
| Cash & ST investments | 920.46M | 501.49M | 639.10M | 439.63M | 475.72M | 499.43M |
| Inventory | 405.86M | 394.21M | 418.77M | 414.61M | 453.33M | 433.62M |
| Total assets | 13.49B | 13.28B | 13.30B | 13.54B | 13.84B | 13.97B |
| Total current liabilities | 3.18B | 2.74B | 3.55B | 2.86B | 3.09B | 3.00B |
| Short-term debt | 480.70M | 101.74M | 92.29M | 98.85M | 99.17M | 102.82M |
| Long-term debt | 6.11B | 6.25B | 5.37B | 6.21B | 6.06B | 6.09B |
| Total liabilities | 10,455,594,000.00 | 10,185,450,000.00 | 10,142,440,000.00 | 10,309,007,000.00 | 10,498,450,000.00 | 10,509,813,000.00 |
| Total equity | 3.03B | 3.10B | 3.16B | 3.23B | 3.34B | 3.46B |
| Retained earnings | 349.50M | 393.74M | 453.28M | 515.84M | 586.26M | 652.31M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.05B | 984.23M | 176.68M | 657.08M | 463.91M | 511.65M | 726.51M | 921.04M |
| Depreciation & amortization | 596.18M | 592.57M | 595.20M | 550.69M | 397.98M | 409.86M | 435.55M | 476.35M |
| Free cash flow | -1.85B | 481.14M | -241.83M | 249.26M | 151.97M | 128.11M | 299.09M | 431.80M |
| Dividends paid | -103.12M | -108.44M | -110.89M | -112.01M | -113.12M | -114.61M | -99.90M | -110.82M |
| Stock buybacks / issuance | -2.90M | -10.91M | 83.48M | 41.59M | 42.95M | 21.94M | 22.18M | -126.85M |
| Ending cash balance | 215.03M | 246.64M | 2.51B | 532.59M | 365.43M | 2.01B | 732.61M | 707.14M |
| Line item | 2025-03 | 2025-06 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | 255.95M | 76.68M | 1.18B | -782.20M | 400.25M | 117.19M |
| Depreciation & amortization | 117.06M | 121.82M | 124.26M | 125.95M | 132.16M | 136.12M |
| Free cash flow | 140.15M | -34.70M | 1.03B | -904.36M | 298.98M | 4.82M |
| Dividends paid | -27.82M | -27.54M | -27.60M | -31.54M | -31.53M | -31.61M |
| Stock buybacks / issuance | -76.31M | -10.83M | -23.13M | -38.07M | -8.97M | 22.98M |
| Ending cash balance | 974.01M | 557.70M | 707.14M | 508.34M | 540.79M | 568.68M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 20.69 | 14.13 | -15.24 | -3.33 | 6.76 | 20.00 | 7.78 | 10.55 |
| ROA %i | 4.59 | 3.27 | -3.13 | -0.60 | 1.32 | 4.22 | 1.78 | 2.51 |
| ROIC %i | 9.10 | 7.00 | -1.74 | 1.62 | 4.41 | 8.63 | 5.02 | 6.71 |
| 5-year avg ROE %i | 15.12 | 15.67 | 10.00 | 6.49 | 4.60 | 4.46 | 3.19 | 8.35 |
| EBIT margin %i | 5.22 | 5.60 | -2.01 | 2.32 | 3.90 | 6.85 | 4.33 | 4.29 |
| FCF / sales %i | -- | 2.62 | -- | 2.06 | 1.87 | 1.62 | 1.72 | 2.33 |
| Current ratioi | 1.17 | 0.98 | 1.99 | 1.01 | 1.00 | 1.04 | 0.81 | 0.99 |
| Quick ratioi | 0.81 | 0.76 | 1.68 | 0.80 | 0.75 | 0.80 | 0.67 | 0.81 |
| Debt / assetsi | 52.80 | 48.65 | 61.68 | 54.49 | 51.62 | 41.13 | 43.92 | 43.01 |
| LT debt / equityi | 238.09 | 199.16 | 347.96 | 283.08 | 252.55 | 143.95 | 149.66 | 178.83 |
| Interest coveragei | 2.34 | 2.58 | -0.66 | 0.68 | 1.67 | 2.93 | 1.94 | 2.18 |
| Revenue CAGR (3Y) %i | 3.29 | 4.02 | -4.23 | -8.50 | -5.52 | 7.83 | 12.89 | 10.58 |
| Net income CAGR (3Y) %i | 34.01 | 15.94 | -- | -- | -24.31 | -- | -- | 18.84 |
| FCF CAGR (3Y) %i | -- | 49.09 | -- | -- | -31.90 | -- | 6.26 | 41.64 |
| Line item | 2025-03 | 2025-06 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | 11.77 | 12.00 | 10.55 | 10.08 | 11.33 | 11.82 |
| ROA %i | 2.67 | 2.80 | 2.51 | 2.41 | 2.61 | 2.81 |
| ROIC %i | 6.46 | 6.67 | 6.71 | 6.23 | 6.43 | 6.62 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 4.65 | 4.70 | 4.29 | 4.23 | 4.33 | 4.40 |
| FCF / sales %i | 2.11 | 1.57 | 2.33 | 1.25 | 2.03 | 2.18 |
| Current ratioi | 1.21 | 1.29 | 0.99 | 1.27 | 1.21 | 1.28 |
| Quick ratioi | 0.99 | 1.04 | 0.81 | 1.03 | 0.96 | 1.03 |
| Debt / assetsi | 50.73 | 49.80 | 43.01 | 48.53 | 46.40 | 46.29 |
| LT debt / equityi | 210.66 | 211.19 | 178.83 | 201.79 | 192.76 | 187.53 |
| Interest coveragei | 2.32 | 2.34 | 2.18 | 2.15 | 2.32 | 2.45 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Food and Support Services (FSS) United States is the largest reported line at 69.13% of revenue, across 2 reported segments.
- Food and Support Services (FSS) International follows at 30.87%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Food and Support Services (FSS) United States69.13%
Food and Support Services (FSS) International30.87%
Quote time 2026-10-08 01:16:42 · For reference only, not investment advice and not tailored to your situation.